Univercells
Univercells uses advanced manufacturing technologies to make "Biologics for all."
Invested: 2020
Modality: Process Innovation
Website: univercells.com
portfolio
Yisheng Biopharma
Yisheng is scaling up undersupplied global health vaccines and developing innovative new biologics.
Invested: 2020
Modality: Vaccine
Website: yishengbio.com
ChromaCode
ChromaCode's HD-PCR technology enhances multiplexing capabilities on existing hardware.
Invested: 2020
Modality: Platform
Website: chromacode.com
54Gene
54gene is using African genetic data to drive discoveries in drug and vaccine development.
Invested: 2020
Modality: Platform
Website: 54gene.com
Codagenix
Codagenix uses emerging computational and synthetic biology tools to rationally design vaccines.
Invested: 2020
Modality: Platform
Website: codagenix.com
AN2 Therapeutics
AN2 is developing novel, broad-spectrum therapeutics for infectious diseases.
Invested: 2019
Modality: Small Molecule
Website: an2therapeutics.com
Themis
Themis is developing novel vaccines for high burden infectious diseases and oncology applications.
Invested: 2019
Modality: Vaccine
Website: themisbio.com
InDevR
InDevR is developing advanced characterization assays for biologics.
Invested: 2019
Modality: Process Innovation
Website: indevr.com